https://en.wikipedia.org/wiki/Microneedles

In biomedical research, the acquisition of platelets has always been a technical bottleneck. The traditional methods require a large number of animals to be bled or volunteers to donate, which is cumbersome, costly, and the sample size and quality obtained each time fluctuate greatly. The emergence of microneedle platelet extraction technology has provided researchers with a new, efficient, standardized, and repeatable tool, and is driving breakthroughs in multiple fields ranging from basic biology to drug development.

In the basic research of platelet biology, the microneedle extraction technique offers unprecedented convenience. Researchers can now conduct multiple, intermittent platelet samplings on the same experimental mouse without sacrificing the animal or performing complex carotid artery insertion surgeries. The microneedle patch only needs to be adhered to the back or ear of the mouse for a few seconds to collect a sufficient amount of platelet samples for flow cytometry, ELISA, or proteomics analysis. This "longitudinal tracking" capability enables researchers to dynamically observe the changes of platelets in different disease models (such as thrombosis, inflammation, tumor metastasis) and provides dynamic rather than static data at a single time point that traditional methods can only offer.

In drug screening, the value of microneedle for extracting platelets is also significant. Many candidate drugs exhibit side effects in the form of abnormal platelet function, such as inhibition of aggregation or induction of activation. Traditional assessment methods require a large amount of whole blood for in vitro experiments, while microneedle technology allows for the direct and real-time collection of platelets from live animals and immediate detection of their responses to the drugs. For example, researchers can collect mouse platelets using microneedles after administering a new anticoagulant drug, and then measure the changes in the aggregation curve every hour to precisely draw the pharmacokinetic curve. This high-throughput and low-cost sampling method significantly accelerates the screening process of candidate drugs.

In regenerative medicine research, platelets extracted by microneedles are widely used to construct "autologous growth factor libraries." In traditional studies, researchers usually used recombinant growth factors, but these factors are expensive, have a short half-life, and lack the synergistic effects of multiple factors secreted by natural platelets. The platelets extracted by microneedles can be directly added to three-dimensional culture scaffolds or hydrogels, releasing dozens of growth factors including PDGF, TGF-β, VEGF, and EGF, to simulate the repair microenvironment in the body. This "natural cocktail" has much better effects in inducing the differentiation of mesenchymal stem cells and promoting angiogenesis than single recombinant factors.

Furthermore, the microneedle platelet extraction technology also provides a new perspective for precision medicine. By analyzing the gene expression profiles of patients' tiny platelets, researchers can predict an individual's response to different treatments. For instance, in cancer immunotherapy, the mRNA and miRNA information carried by platelets can reflect the state of the tumor microenvironment. The painless and minimally invasive nature of microneedles enables this detection to be conducted at a high frequency, allowing for real-time monitoring of treatment effects and dynamic adjustment.

From laboratory to clinical application, microneedle platelet extraction is building a bridge. It brings basic research closer to the real physiological state, makes drug development more efficient and cost-effective, and provides more reliable data support for individualized treatment. When researchers gently apply the microneedle, what they obtain is not just a few microliters of blood, but also a key to unlocking the mysteries of life.